Avantor (NYSE: AVTR) — Perfil da empresa, notícias e dados financeiros
Avantor delivers mission-critical products and services to biopharma and healthcare, aiming to solve complex challenges in life sciences.
Avantor
Avantor is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries. The company manufactures and distributes customized liquid solutions, high-purity chemicals and reagents, laboratory supplies, specialized equipment, and custom workflow solutions. Operating integrated manufacturing facilities, distribution centers, and innovation centers globally, Avantor serves life science research, drug discovery, biomanufacturing scale-up, quality control, and advanced manufacturing processes.
Resumo
Operações
Produtos e/ou serviços de Avantor
- Biopharma Process Solutions: Provision of high-purity process chemicals, cell culture media, single-use fluid handling systems, and customized liquid formulation services supporting upstream and downstream bioprocessing for drug manufacturers globally.
- Laboratory Chemicals and Reagents: Manufacturing and supply of analytical-grade chemicals, high-purity solvents, acids, volumetric solutions, and standards used across research laboratories, quality control, testing facilities, and academic institutions worldwide.
- Laboratory Equipment and Supplies: Distribution of laboratory consumables, personal protective equipment, safety supplies, analytical instruments, and cleanroom products through an integrated e-commerce and global distribution platform network serving scientific research.
- Custom Formulation and Manufacturing: Specialized contract manufacturing of proprietary fluid management systems, custom buffer solutions, precise chemical blends, and validated packaging solutions tailored for commercial pharmaceutical and biotechnology manufacturing.
- Life Sciences Research Consumables: Supply of genomics, proteomics, cell biology, and assay reagents alongside cell culture containers and general labware used in basic research, clinical diagnostics, and discovery workflows.
- Advanced Technologies and Materials: Production of ultra-high-purity silicones, electronic-grade chemicals, and specialized material solutions engineered for medical devices, semiconductor manufacturing, aerospace, and high-performance industrial applications.
equipe executiva do Avantor
- Emmanuel LignerPresident, CEO & Director
- Claudius O. SokenuExecutive VP, Corporate Secretary and Chief Legal & Compliance Officer
- Corey D. WalkerPresident of Laboratory Solutions
- Benoit GourdierExecutive Vice President of Bioscience Production
- Todd W. GarnerExecutive VP & CFO
- Mary BlennExecutive VP & COO
- Steven W. EckSenior VP, Corporate Controller & Chief Accounting Officer
- Michael P. WondraschExecutive VP & Chief Information Officer
- Chris FidykVice President of Investor Relations
- Brittany HankamerExecutive VP & Chief Human Resources Officer
Principais indicadores financeiros
Resultados divulgados pela Avantor, em USD.
- Cap. de mercado
- 11,3 bi
- Receita (TTM)
- 6,6 bi
- P/L
- —
- LPA (diluído, TTM)
- -0.8
- Dividend yield
- —
- Margem de lucro
- -8.8%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 6,6 bi | -246,2 mi | -530,2 mi | |
| 6,8 bi | 1,1 bi | 711,5 mi | |
| 7 bi | 696,4 mi | 321,1 mi | |
| 4,9 bi | 1,1 bi | 686,5 mi |